STRICTLY CONFIDENTIAL Attn: Richard W. PascoeLetter Agreement • September 11th, 2017 • Apricus Biosciences, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 11th, 2017 Company Industry JurisdictionThis letter agreement (this “Agreement”) constitutes the agreement between Apricus Biosciences, Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of securities of the Company (the “Securities”) during the Term (as defined below) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all internal approvals of Wainwright in c
STRICTLY CONFIDENTIALLetter Agreement • September 16th, 2015 • Capstone Therapeutics Corp. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 16th, 2015 Company Industry JurisdictionThis letter agreement (this “Agreement”) constitutes the agreement between Capstone Therapeutics Corp. (excluding the Company’s subsidiary, Lipimetix Development, Inc., the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”) that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of securities of the Company (“Securities”) during the Term (as defined below) of this Agreement The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances an